A technician holds a pipette containing cannabis oil in the state-owned Pharmaceutical Industrial Laboratory as Argentina launched an agency that will regulate the cultivation, industrial production, marketing, and acquisition of seeds of the cannabis plant and hemp for medicinal and industrial purposes and is preparing to regulate the law promulgated in May 2022, in Santa Fe province, Argentina March 1, 2023. REUTERS/Matias Baglietto 

A container with cannabis oil is pictured in the state-owned Pharmaceutical Industrial Laboratory as Argentina launched an agency that will regulate the cultivation, industrial production, marketing, and acquisition of seeds of the cannabis plant and hemp for medicinal and industrial purposes and is preparing to regulate the law promulgated in May 2022, in Santa Fe province, Argentina March 1, 2023. REUTERS/Matias Baglietto 

A technician places a vial to test the quality of cannabis oil at the state-owned Pharmaceutical Industrial Laboratory as Argentina launched an agency that will regulate the cultivation, industrial production, marketing, and acquisition of seeds of the cannabis plant and hemp for medicinal and industrial purposes and is preparing to regulate the law promulgated in May 2022, in Monte Vera, Santa Fe province, Argentina March 1, 2023. REUTERS/Matias Baglietto 

Elida Formente, director of the state-owned Pharmaceutical Industrial Laboratory, holds a bottle of cannabis oil, as Argentina launched an agency that will regulate the cultivation, industrial production, marketing, and acquisition of seeds of the cannabis plant and hemp for medicinal and industrial purposes and is preparing to regulate the law promulgated in May 2022, in Santa Fe province, Argentina March 1, 2023. REUTERS/Matias Baglietto 

Elida Formente, director of the state-owned Pharmaceutical Industrial Laboratory, holds a bottle of cannabis oil as Argentina launched an agency that will regulate the cultivation, industrial production, marketing, and acquisition of seeds of the cannabis plant and hemp for medicinal and industrial purposes and is preparing to regulate the law promulgated in May 2022, in Santa Fe province, Argentina March 1, 2023. REUTERS/Matias Baglietto 

A salesman of a pharmaceutical shop uses his cellphone torch to find medicine to serve customers during a countrywide blackout in Dhaka, Bangladesh, October 4, 2022. REUTERS/Mohammad Ponir Hossain TPX IMAGES OF THE DAY 

A pharmaceutical shop uses candle lights to serve customers during countrywide blackout in Dhaka, Bangladesh, October 4, 2022. REUTERS/Mohammad Ponir Hossain 

A salesman of a pharmaceutical shop uses his cellphone torch to find medicine to serve customers during countrywide blackout in Dhaka, Bangladesh, October 4, 2022. REUTERS/Mohammad Ponir Hossain 

A pharmaceutical shop uses candle lights to serve customers during countrywide blackout in Dhaka, Bangladesh, October 4, 2022. REUTERS/Mohammad Ponir Hossain 

A worker produces cannabis-infused medicine at the Government Pharmaceutical Organization in Pathum Thani province, Thailand, August 17, 2022. REUTERS/Athit Perawongmetha 

Workers produce cannabis-infused medicine at the Government Pharmaceutical Organization in Pathum Thani province, Thailand, August 17, 2022. REUTERS/Athit Perawongmetha 

Workers produce cannabis-infused medicine at the Government Pharmaceutical Organization in Pathum Thani province, Thailand, August 17, 2022. REUTERS/Athit Perawongmetha 

A worker produces cannabis-infused medicine at the Government Pharmaceutical Organization in Pathum Thani province, Thailand, August 17, 2022. REUTERS/Athit Perawongmetha 

A worker produces cannabis-infused medicine at the Government Pharmaceutical Organization in Pathum Thani province, Thailand, August 17, 2022. REUTERS/Athit Perawongmetha 

A worker produces cannabis-infused medicine at the Government Pharmaceutical Organization in Pathum Thani province, Thailand, August 17, 2022. REUTERS/Athit Perawongmetha 

William Anderson, Chief Executive Officer (CEO) of Roche Pharmaceuticals, speaks during an official visit in the Philippines, at Manila Hotel in Manila, Philippines, July 4, 2022. REUTERS/Eloisa Lopez 

William Anderson, Chief Executive Officer (CEO) of Roche Pharmaceuticals, speaks during an official visit in the Philippines, at Manila Hotel in Manila, Philippines, July 4, 2022. REUTERS/Eloisa Lopez 

William Anderson, Chief Executive Officer (CEO) of Roche Pharmaceuticals, speaks during an official visit in the Philippines, at Manila Hotel in Manila, Philippines, July 4, 2022. REUTERS/Eloisa Lopez 

The logo of Sinopharm, China's National Pharmaceutical Group Corporation is pictured in Beijing, China January 18, 2022. REUTERS/Fabrizio Bensch 

Chekkit Technologies founder Dare Odumade poses for a photograph during an interview with Reuters in Lagos, Nigeria December 16, 2021. Picture taken December 16, 2021. REUTERS/Nneka Chile 

Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

A lab employee at Spanish pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

Lab employees of Spanish pharmaceutical company Hipra work at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

Elia Torroella, Vice-President and R&D chief of Spanish pharmaceutical company Hipra, poses after an interview at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

Elia Torroella, Vice-President and R&D chief of Spanish pharmaceutical company Hipra, reacts during an interview at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

A lab employee of Spain's pharmaceutical company Hipra works at its headquarters in Amer, near Girona, Spain, December 2, 2021. Picture taken December 2, 2021. REUTERS/Nacho Doce 

The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in Sant Cugat del Valles, near Barcelona, Spain, September 17, 2021. REUTERS/Albert Gea 

The logo of the Spanish pharmaceuticals company Grifols is pictured on their headquarters' building in Sant Cugat del Valles, near Barcelona, Spain, September 17, 2021. REUTERS/Albert Gea 

The BioNTech logo is seen at the booth of Fosun Pharmaceutical (Group) at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021. REUTERS/Florence Lo 

Canadian Prime Minister Justin Trudeau looks up during a tour of pharmaceutical company Pfizer with Belgian counterpart Alexander De Croo (R) in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

Canadian Prime Minister Justin Trudeau signs a banner during a tour of pharmaceutical company Pfizer with Belgian counterpart Alexander De Croo in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

Canadian Prime Minister Justin Trudeau signs a banner with Belgian counterpart Alexander De Croo and speaks to the media during a tour of pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

Employees check the monitors as Canadian Prime Minister Justin Trudeau gestures during a tour of pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

An employee handles boxes as Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

Canadian Prime Minister Justin Trudeau watches a process during a tour of the pharmaceutical company Pfizer with his Belgian counterpart in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

Canadian Prime Minister Justin Trudeau watches as a worker packs a box during a tour of the pharmaceutical company Pfizer with his Belgian counterpart in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

Belgian Prime Minister Alexander De Croo and Canadian Prime Minister Justin Trudeau tour the pharmaceutical company Pfizer in Puurs, Belgium June 15, 2021. Frederic Sierakowski/Pool via REUTERS 

A sign identifies the lobby of the headquarters of Alexion Pharmaceuticals in Boston, Massachusetts, U.S., May 26, 2021. REUTERS/Brian Snyder 

A sign identifies the lobby of the headquarters of Alexion Pharmaceuticals in Boston, Massachusetts, U.S., May 26, 2021. REUTERS/Brian Snyder 

A sign identifies the lobby of the headquarters of Alexion Pharmaceuticals in Boston, Massachusetts, U.S., May 26, 2021. REUTERS/Brian Snyder 

Doctor Toshiaki Minami, director at Osaka Medical and Pharmaceutical University Hospital, poses for a photograph at a drug storage at the hospital, amid the coronavirus disease (COVID-19) pandemic, in Takatsuki, Osaka prefecture, Japan May 17, 2021. Picture taken May 17, 2021. REUTERS/Akira Tomoshige 

Medical workers at Osaka Medical and Pharmaceutical University Hospital work in the operation wing of the hospital, amid the coronavirus disease (COVID-19) outbreak, in Takatsuki, Osaka prefecture, Japan May 17, 2021. Picture taken May 17, 2021. REUTERS/Akira Tomoshige 

Satsuki Nakayama, director of the nursing department at Osaka Medical and Pharmaceutical University Hospital, works with her colleague in the operation wing of the hospital, amid the coronavirus disease (COVID-19) pandemic, in Takatsuki, Osaka prefecture, Japan May 17, 2021. Picture taken May 17, 2021. REUTERS/Akira Tomoshige 

General view shows Osaka Medical and Pharmaceutical University Hospital, amid the coronavirus disease (COVID-19) outbreak, in Takatsuki Osaka prefecture, Japan May 17, 2021. Picture taken May 17, 2021. REUTERS/Akira Tomoshige 

A medical worker at Osaka Medical and Pharmaceutical University Hospital enters the intensive care unit (ICU) of the hospital, amid the coronavirus disease (COVID-19) pandemic, in Takatsuki, Osaka prefecture, Japan May 17, 2021. Picture taken May 17, 2021. REUTERS/Akira Tomoshige 

Doctor Toshiaki Minami, director at Osaka Medical and Pharmaceutical University Hospital, works with his colleague in the operation wing of the hospital, amid the coronavirus disease (COVID-19) pandemic, in Takatsuki, Osaka prefecture, Japan May 17, 2021. Picture taken May 17, 2021. REUTERS/Akira Tomoshige 

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

Ampules are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

Tablets are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

Tablets are seen on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny 

A logo of pharmaceutical company Zentiva is seen outside the Zentiva factory in Prague, Czech Republic, May 6, 2021. Picture taken May 6, 2021. REUTERS/David W Cerny